کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3415608 | 1224970 | 2006 | 10 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity](/preview/png/3415608.png)
Brucella lumazine synthase (BLS) has been previously used with success as a delivery system for systemic immunization against murine cysticercosis. We herein determined the usefulness of BLS as a new antigen-delivery system and mucosal-adjuvant using KETc1, one of the peptides of the anti-cysticercosis vaccine. A protection of up to 98% was induced when KETc1 was used as a chimera fused to BLS. Used as adjuvant of KETc1, BLS also induced a high level of protection (79%), which did not significantly differ from that induced by the cholera toxin (74%). KETc1 and BLS administered separately also reduced the parasite load. KETc1 administered orally as a chimera, and to a lesser extent with BLS as adjuvant, elicited IgG and IgA specific antibodies, which were detectable both in fecal extracts and in sera, and increased B and CD4 activated cells. BLS-KETc1 also increased the levels of transcription of TNF-α, IL-2 and IFNγ in Peyer's patches, and in spleen, only increased TNF-α was observed. Overall, these results showed that BLS can be used as both an antigen-carrier and as an adjuvant in the design of new oral subunit vaccines.
Journal: Microbes and Infection - Volume 8, Issue 5, April 2006, Pages 1277–1286